Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Scaramucci

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
European Journal of Haematology|May 23, 2020
Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the "Ph1-negative Myeloproliferative Neoplasms Latium Group"Maria Gabriella Mazzucconi, Ermina Baldacci, Roberto Latagliata, et al.
American Journal of Hematology|June 29, 2016
Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of diseaseFabio Efficace, Franco Mandelli, Paola Fazi, et al.
Blood|September 19, 2014
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patientsWilma Barcellini, Bruno Fattizzo, Anna Zaninoni, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
European Journal of Haematology|May 23, 2020
Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the "Ph1-negative Myeloproliferative Neoplasms Latium Group"Maria Gabriella Mazzucconi, Ermina Baldacci, Roberto Latagliata, et al.
American Journal of Hematology|June 29, 2016
Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of diseaseFabio Efficace, Franco Mandelli, Paola Fazi, et al.
Blood|September 19, 2014
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patientsWilma Barcellini, Bruno Fattizzo, Anna Zaninoni, et al.
Pageof 4